Results 1 to 10 of about 1,602 (208)

Case Report: Kawasaki disease associated with acute generalized exanthematous pustulosis secondary to carbocysteine [PDF]

open access: goldFrontiers in Pediatrics
Acute generalized exanthematous pustulosis (AGEP) is an uncommon eruption characterized by sterile pustules on an erythematous background, which is usually associated with drugs. AGEP is described as a self-limiting disease with favorable prognosis.
Takashi Furuta   +5 more
doaj   +10 more sources

Palatability Assessment of Carbocysteine Oral Solution Strawberry Taste Versus Carbocysteine Oral Solution Mint Taste: A Blinded Randomized Study [PDF]

open access: goldFrontiers in Pharmacology, 2022
Objective: To compare and evaluate the palatability of two carbocysteine oral solutions (strawberry vs. mint taste) among healthy children aged 2–12 years.Methods: A randomized, triple-blind, crossover, palatability trial in 42 children aged 2–12 years ...
Yaguang Peng   +4 more
doaj   +7 more sources

Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action [PDF]

open access: goldPharmaceutics, 2022
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with a versatile and complicated profile, being the fourth most common single cause of death worldwide.
Elisabetta Pace   +8 more
doaj   +8 more sources

Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy [PDF]

open access: goldLife, 2022
SARS-CoV-2 infection leads to a heterogenous spectrum of clinical conditions ranging from self-limiting upper airway infection to severe respiratory failure.
Andrea Bianco   +8 more
doaj   +7 more sources

Possible Role of Carbocysteine Syrup in the Deflation of Percutaneous Endoscopic Gastrostomy Balloons [PDF]

open access: goldClinics and Practice, 2023
Percutaneous endoscopic gastrostomy is the method of choice to allow enteral access in patients requiring long-term enteral nutrition. However, although generally safe, percutaneous tube positioning may be plagued by several complications.
Gabrio Bassotti, Danilo Castellani
doaj   +7 more sources

Carbocysteine Modifies Circulating miR-21, IL-8, sRAGE, and fAGEs Levels in Mild Acute Exacerbated COPD Patients: A Pilot Study [PDF]

open access: goldPharmaceuticals, 2022
Patients with Chronic Obstructive Pulmonary Disease (COPD) periodically experience acute exacerbation (AECOPD). Carbocysteine represents a valid add on therapy in COPD by exerting antioxidant and anti-inflammatory activities.
Maria Ferraro   +6 more
doaj   +5 more sources

Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial. [PDF]

open access: goldPLoS ONE, 2016
This study aimed to examine the effects of carbocysteine in OSAS patients.A total of 40 patients with moderate to severe obstructive sleep apnea syndrome (OSAS) were randomly divided into two groups. One group was treated with 1500 mg carbocysteine daily,
Kang Wu   +3 more
doaj   +6 more sources

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine [PDF]

open access: goldRespiratory Research, 2019
Background To date there are no head-to-head studies comparing different mucolytic/antioxidant agents. Considering the inconsistent evidence resulting from the pivotal studies on mucolytic/antioxidant agents tested in chronic obstructive pulmonary ...
Paola Rogliani   +5 more
doaj   +5 more sources

Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey. [PDF]

open access: goldPLoS ONE, 2011
OBJECTIVE: To report pediatric cases of paradoxical respiratory adverse drug reactions (ADRs) after exposure to oral mucolytic drugs (carbocysteine, acetylcysteine) that led to the withdrawal of licenses for these drugs for infants in France and then ...
Pauline Mallet   +6 more
doaj   +8 more sources

Effects of a Long-Term Use of Carbocysteine on Frequency and Duration of Exacerbations in Patients with Bronchiectasis. [PDF]

open access: diamondOpen Access Maced J Med Sci, 2019
BACKGROUND: The failure of mucus clearance in bronchiectasis can be improved by chest physiotherapy or/and mucoactive agents. AIM: To assess the effects of long-term use of carbocysteine on frequency and duration of exacerbations in patients with ...
Minov J   +5 more
europepmc   +6 more sources

Home - About - Disclaimer - Privacy